Currently submitted to: JMIR Mental Health
Date Submitted: Jun 19, 2019
Open Peer Review Period: Jun 20, 2019 - Aug 4, 2019
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note “no longer under consideration” will appear above).
Peer-review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a “Peer-Review Me” button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed “version of record” (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Smartphone-based interventions in German language in affective disorders – a review about currently available products
Currently, numerous new products such as applications (apps) for smartphones are being marketed in the electronic (e)-health sector. Mood-graphs, diagnostic questions, mindfulness exercises and chat-therapy affect psychiatric treatment of affective disorders (ADs) positively. The products are easily available and allow for little control over efficacy and adverse effects.
A systemic review was performed in order to examine the currently available apps that advertise for supporting people with AD and anxiety disorders.
The keywords “psychiatry”, “depression”, “bipolar”, “anxiety”, “mood” in German language were entered in Google Play Store and IOS iTunes and all available products were examined. Furthermore, the current research on these apps should be listed transparently at clinicaltrials.com and PubMed.
Depending on keywords and app store, respectively, 98 to 250 products were spotted. 56 of the apps were included in this paper as they are related to AD. However, only nine of them are supported by scientific research or federal authorities. Five products are currently study subjects in clinical trials, but no publication was available at the time of research. Moreover, five publications of study protocols of other German-language apps, as well as five publications about evaluated products in PubMed were found.
Diverse free apps with potentially favorable effects on mood stabilization are available for people suffering from ADs. As currently only a very small number of them have been scientifically evaluated, there is an urgent need for research in the mobile e-health sector. In addition, physicians and psychotherapists should talk to their patients about the advantages and disadvantages of apps and inform them about the lack of evidence.
Request queued. Please wait while the file is being generated. It may take some time.
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.